| Year |
Citation |
Score |
| 2020 |
Guha TK, Calos MP. Nucleofection of phiC31 Integrase Protein Mediates Sequence-Specific Genomic Integration in Human Cells. Journal of Molecular Biology. PMID 32339531 DOI: 10.1016/J.Jmb.2020.04.019 |
0.581 |
|
| 2019 |
Guha TK, Pichavant C, Calos MP. Plasmid-Mediated Gene Therapy in Mouse Models of Limb Girdle Muscular Dystrophy. Molecular Therapy. Methods & Clinical Development. 15: 294-304. PMID 31890729 DOI: 10.1016/J.Omtm.2019.10.002 |
0.43 |
|
| 2017 |
Geisinger JM, Calos MP. Knock-in Blunt Ligation Utilizing CRISPR/Cas9. Bio-Protocol. 7: e2163. PMID 34458476 DOI: 10.21769/BioProtoc.2163 |
0.313 |
|
| 2017 |
Ma J, Pichavant C, du Bois H, Bhakta M, Calos MP. DNA-Mediated Gene Therapy in a Mouse Model of Limb Girdle Muscular Dystrophy 2B. Molecular Therapy. Methods & Clinical Development. 7: 123-131. PMID 29159199 DOI: 10.1016/J.Omtm.2017.10.005 |
0.416 |
|
| 2017 |
Farruggio AP, Bhakta MS, Calos MP. Use of the DICE (Dual Integrase Cassette Exchange) System. Methods in Molecular Biology (Clifton, N.J.). 1642: 69-85. PMID 28815494 DOI: 10.1007/978-1-4939-7169-5_5 |
0.563 |
|
| 2016 |
Calos MP. Genome editing techniques and their therapeutic applications. Clinical Pharmacology and Therapeutics. PMID 27783398 DOI: 10.1002/Cpt.542 |
0.491 |
|
| 2016 |
Turan S, Farruggio AP, Srifa W, Day JW, Calos MP. Precise correction of disease mutations in induced pluripotent stem cells derived from patients with limb girdle muscular dystrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26916285 DOI: 10.1038/Mt.2016.40 |
0.439 |
|
| 2016 |
Geisinger JM, Turan S, Hernandez S, Spector LP, Calos MP. In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining. Nucleic Acids Research. 44: e76. PMID 26762978 DOI: 10.1093/Nar/Gkv1542 |
0.472 |
|
| 2015 |
Geisinger JM, Calos MP. Using phage integrases in a site-specific dual integrase cassette exchange strategy. Methods in Molecular Biology (Clifton, N.J.). 1239: 29-38. PMID 25408400 DOI: 10.1007/978-1-4939-1862-1_3 |
0.555 |
|
| 2014 |
Farruggio AP, Calos MP. Serine integrase chimeras with activity in E. coli and HeLa cells. Biology Open. 3: 895-903. PMID 25217617 DOI: 10.1242/Bio.20148748 |
0.485 |
|
| 2014 |
Zhao C, Farruggio AP, Bjornson CR, Chavez CL, Geisinger JM, Neal TL, Karow M, Calos MP. Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells. Plos One. 9: e96279. PMID 24781921 DOI: 10.1371/Journal.Pone.0096279 |
0.836 |
|
| 2014 |
Zhu F, Gamboa M, Farruggio AP, Hippenmeyer S, Tasic B, Schüle B, Chen-Tsai Y, Calos MP. DICE, an efficient system for iterative genomic editing in human pluripotent stem cells. Nucleic Acids Research. 42: e34. PMID 24304893 DOI: 10.1093/Nar/Gkt1290 |
0.522 |
|
| 2013 |
Tremblay JP, Xiao X, Aartsma-Rus A, Barbas C, Blau HM, Bogdanove AJ, Boycott K, Braun S, Breakefield XO, Bueren JA, Buschmann M, Byrne BJ, Calos M, Cathomen T, Chamberlain J, et al. Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 266-8. PMID 23369965 DOI: 10.1038/Mt.2013.4 |
0.415 |
|
| 2012 |
Lan F, Liu J, Narsinh KH, Hu S, Han L, Lee AS, Karow M, Nguyen PK, Nag D, Calos MP, Robbins RC, Wu JC. Safe genetic modification of cardiac stem cells using a site-specific integration technique. Circulation. 126: S20-8. PMID 22965984 DOI: 10.1161/Circulationaha.111.084913 |
0.438 |
|
| 2012 |
Farruggio AP, Chavez CL, Mikell CL, Calos MP. Efficient reversal of phiC31 integrase recombination in mammalian cells. Biotechnology Journal. 7: 1332-6. PMID 22933343 DOI: 10.1002/Biot.201200283 |
0.836 |
|
| 2012 |
Hillman RT, Calos MP. Site-specific integration with bacteriophage ΦC31 integrase. Cold Spring Harbor Protocols. 2012. PMID 22550292 DOI: 10.1101/Pdb.Prot069211 |
0.574 |
|
| 2012 |
Chavez CL, Keravala A, Chu JN, Farruggio AP, Cuéllar VE, Voorberg J, Calos MP. Long-term expression of human coagulation factor VIII in a tolerant mouse model using the φC31 integrase system. Human Gene Therapy. 23: 390-8. PMID 22077817 DOI: 10.1089/Hum.2011.110 |
0.835 |
|
| 2011 |
Karow M, Chavez CL, Farruggio AP, Geisinger JM, Keravala A, Jung WE, Lan F, Wu JC, Chen-Tsai Y, Calos MP. Site-specific recombinase strategy to create induced pluripotent stem cells efficiently with plasmid DNA. Stem Cells (Dayton, Ohio). 29: 1696-704. PMID 21898697 DOI: 10.1002/Stem.730 |
0.816 |
|
| 2011 |
Chavez CL, Calos MP. Therapeutic applications of the ΦC31 integrase system. Current Gene Therapy. 11: 375-81. PMID 21888619 DOI: 10.2174/156652311797415818 |
0.839 |
|
| 2011 |
Karow M, Calos MP. The therapeutic potential of ΦC31 integrase as a gene therapy system. Expert Opinion On Biological Therapy. 11: 1287-96. PMID 21736536 DOI: 10.1517/14712598.2011.601293 |
0.528 |
|
| 2011 |
Keravala A, Chavez CL, Hu G, Woodard LE, Monahan PE, Calos MP. Long-term phenotypic correction in factor IX knockout mice by using ΦC31 integrase-mediated gene therapy. Gene Therapy. 18: 842-8. PMID 21412285 DOI: 10.1038/Gt.2011.31 |
0.857 |
|
| 2011 |
Ito M, Yamanouchi K, Naito K, Calos MP, Tojo H. Site-specific integration of transgene targeting an endogenous lox-like site in early mouse embryos. Journal of Applied Genetics. 52: 89-94. PMID 21110150 DOI: 10.1007/S13353-010-0011-3 |
0.579 |
|
| 2010 |
Woodard LE, Keravala A, Jung WE, Wapinski OL, Yang Q, Felsher DW, Calos MP. Impact of hydrodynamic injection and phiC31 integrase on tumor latency in a mouse model of MYC-induced hepatocellular carcinoma. Plos One. 5: e11367. PMID 20614008 DOI: 10.1371/Journal.Pone.0011367 |
0.445 |
|
| 2010 |
Chavez CL, Keravala A, Woodard LE, Hillman RT, Stowe TR, Chu JN, Calos MP. Kinetics and longevity of ΦC31 integrase in mouse liver and cultured cells. Human Gene Therapy. 21: 1287-97. PMID 20497035 DOI: 10.1089/Hum.2010.049 |
0.839 |
|
| 2010 |
Woodard LE, Hillman RT, Keravala A, Lee S, Calos MP. Effect of nuclear localization and hydrodynamic delivery-induced cell division on phiC31 integrase activity. Gene Therapy. 17: 217-26. PMID 19847205 DOI: 10.1038/Gt.2009.136 |
0.502 |
|
| 2009 |
Keravala A, Lee S, Thyagarajan B, Olivares EC, Gabrovsky VE, Woodard LE, Calos MP. Mutational derivatives of PhiC31 integrase with increased efficiency and specificity Molecular Therapy. 17: 112-120. PMID 19002165 DOI: 10.1038/Mt.2008.241 |
0.834 |
|
| 2008 |
Gabrovsky V, Calos MP. Factoring nonviral gene therapy into a cure for hemophilia A. Current Opinion in Molecular Therapeutics. 10: 464-70. PMID 18830922 |
0.384 |
|
| 2008 |
Keravala A, Ormerod BK, Palmer TD, Calos MP. Long-term transgene expression in mouse neural progenitor cells modified with phiC31 integrase. Journal of Neuroscience Methods. 173: 299-305. PMID 18606184 DOI: 10.1016/J.Jneumeth.2008.06.005 |
0.574 |
|
| 2008 |
Keravala A, Calos MP. Site-specific chromosomal integration mediated by phiC31 integrase. Methods in Molecular Biology (Clifton, N.J.). 435: 165-73. PMID 18370075 DOI: 10.1007/978-1-59745-232-8_12 |
0.535 |
|
| 2007 |
Fish MP, Groth AC, Calos MP, Nusse R. Creating transgenic Drosophila by microinjecting the site-specific phiC31 integrase mRNA and a transgene-containing donor plasmid. Nature Protocols. 2: 2325-31. PMID 17947973 DOI: 10.1038/Nprot.2007.328 |
0.838 |
|
| 2006 |
Calos MP. The phiC31 integrase system for gene therapy. Current Gene Therapy. 6: 633-45. PMID 17168696 DOI: 10.2174/156652306779010642 |
0.562 |
|
| 2006 |
Portlock JL, Keravala A, Bertoni C, Lee S, Rando TA, Calos MP. Long-term increase in mVEGF164 in mouse hindlimb muscle mediated by phage phiC31 integrase after nonviral DNA delivery. Human Gene Therapy. 17: 871-6. PMID 16942446 DOI: 10.1089/Hum.2006.17.871 |
0.829 |
|
| 2006 |
Chalberg TW, Vankov A, Molnar FE, Butterwick AF, Huie P, Calos MP, Palanker DV. Gene transfer to rabbit retina with electron avalanche transfection. Investigative Ophthalmology & Visual Science. 47: 4083-90. PMID 16936128 DOI: 10.1167/Iovs.06-0092 |
0.79 |
|
| 2006 |
Keravala A, Portlock JL, Nash JA, Vitrant DG, Robbins PD, Calos MP. PhiC31 integrase mediates integration in cultured synovial cells and enhances gene expression in rabbit joints. The Journal of Gene Medicine. 8: 1008-17. PMID 16779871 DOI: 10.1002/Jgm.928 |
0.837 |
|
| 2006 |
Keravala A, Groth AC, Jarrahian S, Thyagarajan B, Hoyt JJ, Kirby PJ, Calos MP. A diversity of serine phage integrases mediate site-specific recombination in mammalian cells. Molecular Genetics and Genomics : Mgg. 276: 135-46. PMID 16699779 DOI: 10.1007/S00438-006-0129-5 |
0.846 |
|
| 2006 |
Ishikawa Y, Tanaka N, Murakami K, Uchiyama T, Kumaki S, Tsuchiya S, Kugoh H, Oshimura M, Calos MP, Sugamura K. Phage phiC31 integrase-mediated genomic integration of the common cytokine receptor gamma chain in human T-cell lines. The Journal of Gene Medicine. 8: 646-53. PMID 16508910 DOI: 10.1002/Jgm.891 |
0.46 |
|
| 2006 |
Chalberg TW, Portlock JL, Olivares EC, Thyagarajan B, Kirby PJ, Hillman RT, Hoelters J, Calos MP. Integration specificity of phage phiC31 integrase in the human genome. Journal of Molecular Biology. 357: 28-48. PMID 16414067 DOI: 10.1016/J.Jmb.2005.11.098 |
0.841 |
|
| 2006 |
Bertoni C, Jarrahian S, Wheeler TM, Li Y, Olivares EC, Calos MP, Rando TA. Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration. Proceedings of the National Academy of Sciences of the United States of America. 103: 419-24. PMID 16387861 DOI: 10.1073/Pnas.0504505102 |
0.805 |
|
| 2006 |
Palanker D, Chalberg T, Vankov A, Huie P, Molnar FE, Butterwick A, Calos M, Marmor M, Blumenkranz MS. Plasma-mediated transfection of RPE Progress in Biomedical Optics and Imaging - Proceedings of Spie. 6138. DOI: 10.1117/12.649624 |
0.797 |
|
| 2006 |
Woodard LE, Keravala A, Hillman RT, Sage J, Calos MP. 863. Liver Gene Therapy for Hemophilia with phiC31 Integrase Molecular Therapy. 13: S332. DOI: 10.1016/J.Ymthe.2006.08.949 |
0.529 |
|
| 2006 |
Keravala A, Lee S, Olivares EC, Thyagarajan B, Farruggio A, Gabrovsky VE, Calos MP. 525. Mutants of phiC31 Integrase with Increased Efficiency and Specificity Molecular Therapy. 13: S201-S202. DOI: 10.1016/J.Ymthe.2006.08.596 |
0.84 |
|
| 2006 |
Hillman RT, Woodard LE, Calos MP. 1075. Cellular Localization and Cell Cycle Dynamics of φC31 Integrase in Mammalian Cells Molecular Therapy. 13: S412. DOI: 10.1016/J.Ymthe.2006.08.1175 |
0.447 |
|
| 2006 |
Bertoni C, Jarrahian S, Wheeler TM, Li Y, Olivares EC, Calos MP, Rando TA. 34. Phi C31 Integrase System Enhances Dystrophin Gene Expression in Skeletal Muscle of Mouse Models for Duchenne Muscular Dystrophy Molecular Therapy. 13: S14-S15. DOI: 10.1016/J.Ymthe.2006.08.047 |
0.754 |
|
| 2005 |
Held PK, Olivares EC, Aguilar CP, Finegold M, Calos MP, Grompe M. In Vivo Correction of Murine Hereditary Tyrosinemia Type I by ϕC31 Integrase-Mediated Gene Delivery. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 399-408. PMID 28192681 DOI: 10.1016/j.ymthe.2004.11.001 |
0.828 |
|
| 2005 |
Ginsburg DS, Calos MP. Site-specific integration with phiC31 integrase for prolonged expression of therapeutic genes. Advances in Genetics. 54: 179-87. PMID 16096012 DOI: 10.1016/S0065-2660(05)54008-2 |
0.869 |
|
| 2005 |
Thyagarajan B, Calos MP. Site-specific integration for high-level protein production in mammalian cells Methods in Molecular Biology (Clifton, N.J.). 308: 99-106. PMID 16082029 DOI: 10.1385/1-59259-922-2:099 |
0.412 |
|
| 2005 |
Chalberg TW, Genise HL, Vollrath D, Calos MP. phiC31 integrase confers genomic integration and long-term transgene expression in rat retina. Investigative Ophthalmology & Visual Science. 46: 2140-6. PMID 15914635 DOI: 10.1167/Iovs.04-1252 |
0.822 |
|
| 2005 |
Held PK, Olivares EC, Aguilar CP, Finegold M, Calos MP, Grompe M. In vivo correction of murine hereditary tyrosinemia type I by phiC31 integrase-mediated gene delivery. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 399-408. PMID 15727936 DOI: 10.1016/J.Ymthe.2004.11.001 |
0.837 |
|
| 2005 |
Keravala A, Hoelters J, Jarrahian S, Chalberg TW, Ciccarella M, Neth P, Calos MP. 1103. Site-Specific Chromosomal Integration in Human Mesenchymal Stem Cells Mediated by PhiC31 Integrase Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.651 |
0.874 |
|
| 2005 |
Gilbert R, Desfossé L, Mairey É, Raymond B, Calos MP, Tremblay JP, Massie B. 884. Integration of a Helper-Dependent Adenovirus Mediated by the Phage |[Phi]|C31 Integrase Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.427 |
0.572 |
|
| 2005 |
Ehrhardt A, Yant SR, Jeff GA, Xu H, Calos MP, Kay MA. 821. Development of a Site-Specific Integrating Gene-Deleted Adenoviral Vector for Sustained Transgene Expression Levels In Vivo Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.364 |
0.612 |
|
| 2005 |
Chalberg TW, Vankov A, Huie P, Molnar FE, Calos MP, Palanker DV. 770. Novel Physical Methods for Nonviral DNA Transfer to Rabbit Retina Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.311 |
0.802 |
|
| 2005 |
Bertoni C, Jarrahian S, Wheeler TM, Li Y, Olivares EC, Calos MP, Rando TA. 265. Enhanced Plasmid-Mediated Dystrophin Expression in the mdx Mouse Model for Duchenne Muscular Dystrophy by a PhiC31 Integrase Plasmid System Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.268 |
0.766 |
|
| 2005 |
Quenneville SP, Chapdelaine P, Rousseau J, Calos MP, Tremblay JP. 257. Ex Vivo Gene Therapy for Duchenne Muscular Dystrophy: Lentiviral and PhiC31 Integrase Approaches Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.260 |
0.396 |
|
| 2005 |
Hoyt JJ, Keravala A, Duda J, Contag CH, Calos MP. 195. Non-Viral, Site-Specific Gene Transfer into Murine Hematopoietic Stem Cells Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.198 |
0.598 |
|
| 2005 |
Portlock JL, Chalberg TW, Olivares EC, Thyagarajan B, Kirby PJ, Calos MP. 194. Characteristics of Site-Specific Integration as Mediated by PhiC31 Integrase in the Human Genome Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.197 |
0.854 |
|
| 2004 |
Quenneville SP, Chapdelaine P, Rousseau J, Beaulieu J, Caron NJ, Skuk D, Mills P, Olivares EC, Calos MP, Tremblay JP. Nucleofection of muscle-derived stem cells and myoblasts with φC31 integrase: Stable expression of a full-length-dystrophin fusion gene by human myoblasts Molecular Therapy. 10: 679-687. PMID 15451452 DOI: 10.1016/J.Ymthe.2004.05.034 |
0.834 |
|
| 2004 |
Dorigo O, Gil JS, Gallaher SD, Tan BT, Castro MG, Lowenstein PR, Calos MP, Berk AJ. Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells. Journal of Virology. 78: 6556-66. PMID 15163748 DOI: 10.1128/Jvi.78.12.6556-6566.2004 |
0.519 |
|
| 2004 |
Groth AC, Fish M, Nusse R, Calos MP. Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31. Genetics. 166: 1775-82. PMID 15126397 DOI: 10.1534/Genetics.166.4.1775 |
0.858 |
|
| 2004 |
Groth AC, Calos MP. Phage integrases: biology and applications. Journal of Molecular Biology. 335: 667-78. PMID 14687564 DOI: 10.1016/J.Jmb.2003.09.082 |
0.851 |
|
| 2004 |
Hollis RP, Nightingale S, Calos MP, Kohn DB. 1037. Site-Specific Genomic Integration in Hematopoietic Cells Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.982 |
0.6 |
|
| 2004 |
Chalberg TW, Ginsburg DS, Kirby PJ, Olivares EC, Portlock JL, Thyagarajan B, Calos MP. 814. Integration Sites Used by the PhiC31 Site-Specific Integrase in the Human Genome Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.712 |
0.834 |
|
| 2004 |
Ehrhardt A, Engler JA, Calos MP, Kay MA. 811. The Hotspots of Integration Targeted by the Site-Specific Integrase PhiC31 May Be Cell Line Dependent Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.709 |
0.577 |
|
| 2004 |
Wheeler TM, Jarrahian S, Bertoni C, Olivares EC, Doyle T, Contag CH, Calos MP, Rando TA. 810. Site-Specific Integration Enhances Expression of DNA Introduced into Skeletal Muscle Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.708 |
0.845 |
|
| 2004 |
Keravala A, Nash J, Portlock JL, Robbins PD, Calos MP. 809. PhiC31 Integrase Mediates Site-Specific Genomic Integration in Rabbit Cells and Rabbit Knee Joints Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.707 |
0.877 |
|
| 2004 |
Chalberg TW, Genise HL, Vollrath D, Calos MP. 1056. PhiC31 Integrase for Long-Term Non-Viral Gene Therapy in Rat Retina Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.1001 |
0.854 |
|
| 2004 |
Quenneville SP, Chapdelaine P, Rousseau J, Caron NJ, Skuk D, Olivares EC, Calos MP, Tremblay JP. 152. Nucleofection and phage phiC31 integrase mediate stable introduction of a dystrophin fusion gene into muscle derived stem cell and human myoblasts Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.075 |
0.83 |
|
| 2003 |
Hollis RP, Stoll SM, Sclimenti CR, Lin J, Chen-Tsai Y, Calos MP. Phage integrases for the construction and manipulation of transgenic mammals. Reproductive Biology and Endocrinology : Rb&E. 1: 79. PMID 14613545 DOI: 10.1186/1477-7827-1-79 |
0.852 |
|
| 2003 |
Portlock JL, Calos MP. Site-specific genomic strategies for gene therapy. Current Opinion in Molecular Therapeutics. 5: 376-82. PMID 14513680 |
0.851 |
|
| 2003 |
Ortiz-Urda S, Thyagarajan B, Keene DR, Lin Q, Calos MP, Khavari PA. PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa. Human Gene Therapy. 14: 923-8. PMID 12828862 DOI: 10.1089/104303403765701204 |
0.521 |
|
| 2003 |
Sclimenti CR, Neviaser AS, Baba EJ, Meuse L, Kay MA, Calos MP. Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice Biotechnology Progress. 19: 144-151. PMID 12573017 DOI: 10.1021/Bp0200907 |
0.852 |
|
| 2003 |
Olivares EC, Calos MP. Phage φC31 integrase-mediated site-specific integration for gene therapy Gene Therapy and Regulation. 2: 103-120. DOI: 10.1163/156855803322664600 |
0.855 |
|
| 2002 |
Olivares EC, Hollis RP, Chalberg TW, Meuse L, Kay MA, Calos MP. Site-specific genomic integration produces therapeutic factor IX levels in mice Nature Biotechnology. 20: 1124-1128. PMID 12379870 DOI: 10.1038/Nbt753 |
0.856 |
|
| 2002 |
Ortiz-Urda S, Thyagarajan B, Keene DR, Lin Q, Fang M, Calos MP, Khavari PA. Stable nonviral genetic correction of inherited human skin disease Nature Medicine. 8: 1166-1170. PMID 12244305 DOI: 10.1038/Nm766 |
0.554 |
|
| 2002 |
Stoll SM, Calos MP. Extrachromosomal plasmid vectors for gene therapy. Current Opinion in Molecular Therapeutics. 4: 299-305. PMID 12222867 |
0.393 |
|
| 2002 |
Stoll SM, Ginsburg DS, Calos MP. Phage TP901-1 site-specific integrase functions in human cells. Journal of Bacteriology. 184: 3657-63. PMID 12057961 DOI: 10.1128/Jb.184.13.3657-3663.2002 |
0.846 |
|
| 2001 |
Sclimenti CR, Thyagarajan B, Calos MP. Directed evolution of a recombinase for improved genomic integration at a native human sequence Nucleic Acids Research. 29: 5044-5051. PMID 11812835 DOI: 10.1093/Nar/29.24.5044 |
0.856 |
|
| 2001 |
Olivares EC, Hollis RP, Calos MP. Phage R4 integrase mediates site-specific integration in human cells. Gene. 278: 167-76. PMID 11707334 DOI: 10.1016/S0378-1119(01)00711-9 |
0.801 |
|
| 2001 |
Stoll SM, Sclimenti CR, Baba EJ, Meuse L, Kay MA, Calos MP. Epstein-Barr virus/human vector provides high-level, long-term expression of α1-antitrypsin in mice Molecular Therapy. 4: 122-129. PMID 11482983 DOI: 10.1006/Mthe.2001.0429 |
0.865 |
|
| 2001 |
Thyagarajan B, Olivares EC, Hollis RP, Ginsburg DS, Calos MP. Site-specific genomic integration in mammalian cells mediated by phage φC31 integrase Molecular and Cellular Biology. 21: 3926-3934. PMID 11359900 DOI: 10.1128/Mcb.21.12.3926-3934.2001 |
0.851 |
|
| 2000 |
Sclimenti CR, Baba EJ, Calos MP. An extrachromosomal tetracycline-regulatable system for mammalian cells. Nucleic Acids Research. 28: E80. PMID 10954613 DOI: 10.1093/Nar/28.17.E80 |
0.823 |
|
| 2000 |
Groth AC, Olivares EC, Thyagarajan B, Calos MP. A phage integrase directs efficient site-specific integration in human cells Proceedings of the National Academy of Sciences of the United States of America. 97: 5995-6000. PMID 10801973 DOI: 10.1073/Pnas.090527097 |
0.847 |
|
| 2000 |
Thyagarajan B, Guimarães MJ, Groth AC, Calos MP. Mammalian genomes contain active recombinase recognition sites Gene. 244: 47-54. PMID 10689186 DOI: 10.1016/S0378-1119(00)00008-1 |
0.864 |
|
| 1999 |
Phillips JE, Calos MP. Effects of homology length and donor vector arrangement on the efficiency of double-strand break-mediated recombination in human cells. Somatic Cell and Molecular Genetics. 25: 91-100. PMID 11225059 DOI: 10.1023/B:Scam.0000007144.05961.2E |
0.512 |
|
| 1999 |
Phillips JE, Thyagarajan B, Calos MP. Epstein-Barr virus plasmid model system for analyzing recombination in human cells Plasmid. 41: 198-206. PMID 10366525 DOI: 10.1006/Plas.1999.1395 |
0.54 |
|
| 1998 |
Calos MP, Sclimenti CR. Assaying extrachromosomal gene therapy vectors that carry replication/persistence elements. Advanced Drug Delivery Reviews. 30: 13-21. PMID 10837598 DOI: 10.1016/S0169-409X(97)00103-8 |
0.836 |
|
| 1998 |
Sclimenti CR, Calos MP. Epstein-Barr virus vectors for gene expression and transfer. Current Opinion in Biotechnology. 9: 476-9. PMID 9821275 DOI: 10.1016/S0958-1669(98)80032-3 |
0.831 |
|
| 1998 |
Bulboaca GH, Deng H, Dewhurst S, Calos MP. Telomeric sequences from human herpesvirus 6 do not mediate nuclear retention of episomal DNA in human cells Archives of Virology. 143: 563-570. PMID 9572556 DOI: 10.1007/S007050050312 |
0.45 |
|
| 1997 |
Calos MP. The potential of extrachromosomal replicating vectors for gene therapy. Trends in Genetics : Tig. 12: 463-6. PMID 8973156 DOI: 10.1016/0168-9525(96)40049-X |
0.447 |
|
| 1995 |
Wohlgemuth JG, Bulboaca GH, Moghadam M, Caddle MS, Calos MP. Physical mapping of origins of replication in the fission yeast Schizosaccharomyces pombe. Molecular Biology of the Cell. 5: 839-49. PMID 7803852 DOI: 10.1091/Mbc.5.8.839 |
0.41 |
|
| 1995 |
Smith JG, Caddle MS, Bulboaca GH, Wohlgemuth JG, Baum M, Clarke L, Calos MP. Replication of centromere II of Schizosaccharomyces pombe. Molecular and Cellular Biology. 15: 5165-72. PMID 7651433 DOI: 10.1128/Mcb.15.9.5165 |
0.419 |
|
| 1995 |
Smith JG, Calos MP. Autonomous replication in Drosophila melanogaster tissue culture cells. Chromosoma. 103: 597-605. PMID 7587582 DOI: 10.1007/Bf00357686 |
0.515 |
|
| 1994 |
Krysan PJ, Calos MP. Epstein-Barr virus-based vectors that replicate in rodent cells. Gene. 136: 137-43. PMID 8293997 DOI: 10.1016/0378-1119(93)90457-E |
0.491 |
|
| 1994 |
Haase SB, Heinzel SS, Calos MP. Transcription inhibits the replication of autonomously replicating plasmids in human cells. Molecular and Cellular Biology. 14: 2516-24. PMID 8139554 DOI: 10.1128/Mcb.14.4.2516 |
0.708 |
|
| 1994 |
Caddle MS, Calos MP. Specific initiation at an origin of replication from Schizosaccharomyces pombe. Molecular and Cellular Biology. 14: 1796-805. PMID 8114712 DOI: 10.1128/Mcb.14.3.1796 |
0.438 |
|
| 1993 |
Tran CT, Caddle MS, Calos MP. The replication behavior of Saccharomyces cerevisiae DNA in human cells. Chromosoma. 102: 129-136. PMID 8432194 DOI: 10.1007/Bf00356030 |
0.481 |
|
| 1993 |
Krysan PJ, Smith JG, Calos MP. Autonomous replication in human cells of multimers of specific human and bacterial DNA sequences. Molecular and Cellular Biology. 13: 2688-96. PMID 8386315 DOI: 10.1128/Mcb.13.5.2688 |
0.447 |
|
| 1993 |
Caddle MS, Calos MP. Analysis of the autonomous replication behavior in human cells of the dihydrofolate reductase putative chromosomal origin of replication. Nucleic Acids Research. 20: 5971-8. PMID 1461730 DOI: 10.1093/Nar/20.22.5971 |
0.503 |
|
| 1991 |
Krysan PJ, Calos MP. Replication initiates at multiple locations on an autonomously replicating plasmid in human cells. Molecular and Cellular Biology. 11: 1464-72. PMID 1996103 DOI: 10.1128/Mcb.11.3.1464 |
0.464 |
|
| 1991 |
Heinzel SS, Krysan PJ, Tran CT, Calos MP. Autonomous DNA replication in human cells is affected by the size and the source of the DNA. Molecular and Cellular Biology. 11: 2263-72. PMID 1900922 DOI: 10.1128/Mcb.11.4.2263 |
0.45 |
|
| 1991 |
Haase SB, Calos MP. Replication control of autonomously replicating human sequences. Nucleic Acids Research. 19: 5053-8. PMID 1656387 DOI: 10.1093/Nar/19.18.5053 |
0.73 |
|
| 1989 |
Hsia HC, Lebkowski JS, Leong PM, Calos MP, Miller JH. Comparison of ultraviolet irradiation-induced mutagenesis of the lacI gene in Escherichia coli and in human 293 cells. Journal of Molecular Biology. 205: 103-13. PMID 2647996 DOI: 10.1016/0022-2836(89)90368-9 |
0.617 |
|
| 1989 |
Krysan PJ, Haase SB, Calos MP. Isolation of human sequences that replicate autonomously in human cells. Molecular and Cellular Biology. 9: 1026-33. PMID 2542763 DOI: 10.1128/Mcb.9.3.1026 |
0.731 |
|
| 1989 |
Haase SB, Heinzel SS, Krysan PJ, Calos MP. Improved EBV shuttle vectors. Mutation Research. 220: 125-32. PMID 2538736 DOI: 10.1016/0165-1110(89)90018-3 |
0.733 |
|
| 1988 |
DuBridge RB, Calos MP. Recombinant shuttle vectors for the study of mutation in mammalian cells. Mutagenesis. 3: 1-9. PMID 3282139 DOI: 10.1093/Mutage/3.1.1 |
0.362 |
|
| 1988 |
Heinzel SS, Krysan PJ, Calos MP, DuBridge RB. Use of simian virus 40 replication to amplify Epstein-Barr virus shuttle vectors in human cells. Journal of Virology. 62: 3738-46. PMID 2843671 DOI: 10.1128/Jvi.62.10.3738-3746.1988 |
0.388 |
|
| 1987 |
DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Molecular and Cellular Biology. 7: 379-87. PMID 3031469 DOI: 10.1128/Mcb.7.1.379 |
0.583 |
|
| 1987 |
DuBridge RB, Calos MP. Molecular approaches to the study of gene mutation in human cells Trends in Genetics. 3: 293-297. DOI: 10.1016/0168-9525(87)90271-X |
0.416 |
|
| 1986 |
Lebkowski JS, Miller JH, Calos MP. Determination of DNA sequence changes induced by ethyl methanesulfonate in human cells, using a shuttle vector system. Molecular and Cellular Biology. 6: 1838-42. PMID 3023907 DOI: 10.1128/Mcb.6.5.1838 |
0.613 |
|
| 1985 |
Lebkowski JS, DuBridge RB, Antell EA, Greisen KS, Calos MP. Transfected DNA is mutated in monkey, mouse, and human cells. Molecular and Cellular Biology. 4: 1951-60. PMID 6095032 DOI: 10.1128/Mcb.4.10.1951 |
0.424 |
|
| 1985 |
Lebkowski JS, Clancy S, Miller JH, Calos MP. The lacI shuttle: rapid analysis of the mutagenic specificity of ultraviolet light in human cells. Proceedings of the National Academy of Sciences of the United States of America. 82: 8606-10. PMID 3001711 DOI: 10.1073/Pnas.82.24.8606 |
0.643 |
|
| 1985 |
DuBridge RB, Lusky M, Botchan MR, Calos MP. Amplification of a bovine papillomavirus-simian virus 40 chimera. Journal of Virology. 56: 625-7. PMID 2997482 DOI: 10.1128/Jvi.56.2.625-627.1985 |
0.407 |
|
| 1985 |
Lebkowski JS, Clancy S, Calos MP. Simian virus 40 replication in adenovirus-transformed human cells antagonizes gene expression. Nature. 317: 169-171. PMID 2993921 DOI: 10.1038/317169A0 |
0.453 |
|
| 1984 |
Clancy S, Mann C, Davis RW, Calos MP. Deletion of plasmid sequences during Saccharomyces cerevisiae transformation. Journal of Bacteriology. 159: 1065-7. PMID 6090387 DOI: 10.1128/Jb.159.3.1065-1067.1984 |
0.312 |
|
| 1984 |
Miller J, Lebkowski J, Greisen K, Calos M. Specificity of mutations induced in transfected DNA by mammalian cells. The Embo Journal. 3: 3117-3121. DOI: 10.1002/J.1460-2075.1984.Tb02267.X |
0.59 |
|
| 1983 |
Calos M. Genomic reorganization: mobile genetic elements. Science. 221: 1366-1367. PMID 17759003 DOI: 10.1126/Science.221.4618.1366 |
0.319 |
|
| 1983 |
Calos MP, Lebkowski JS, Botchan MR. High mutation frequency in DNA transfected into mammalian cells. Proceedings of the National Academy of Sciences of the United States of America. 80: 3015-9. PMID 6574469 DOI: 10.1073/Pnas.80.10.3015 |
0.456 |
|
| 1982 |
Albertini AM, Hofer M, Calos MP, Tlsty TD, Miller JH. Analysis of spontaneous deletions and gene amplification in the lac region of Escherichia coli Cold Spring Harbor Symposia On Quantitative Biology. 47: 841-850. PMID 6345079 DOI: 10.1101/Sqb.1983.047.01.096 |
0.598 |
|
| 1982 |
Albertini AM, Hofer M, Calos MP, Miller JH. On the formation of spontaneous deletions: the importance of short sequence homologies in the generation of large deletions. Cell. 29: 319-28. PMID 6288254 DOI: 10.1016/0092-8674(82)90148-9 |
0.599 |
|
| 1981 |
Miller JH, Calos MP, Combépine C, Hofer M. Further correlations of the lacI genetic map with the DNA sequence. Journal of Molecular Biology. 153: 65-6. PMID 7040680 DOI: 10.1016/0022-2836(81)90526-X |
0.56 |
|
| 1981 |
Calos MP, Miller JH. Genetic and sequence analysis of frameshift mutations induced by ICR-191. Journal of Molecular Biology. 153: 39-64. PMID 7040679 DOI: 10.1016/0022-2836(81)90525-8 |
0.579 |
|
| 1981 |
Calos MP, Miller JH. The DNA sequence change resulting from the IQ1 mutation, which greatly increases promoter strength. Molecular & General Genetics : Mgg. 183: 559-60. PMID 7038381 DOI: 10.1007/Bf00268783 |
0.581 |
|
| 1981 |
Miller JH, Calos MP, Galas DJ. Genetic and sequencing studies of the specificity of transposition into the lac region of E. coli. Cold Spring Harbor Symposia On Quantitative Biology. 45: 243-57. PMID 6271472 DOI: 10.1101/Sqb.1981.045.01.037 |
0.548 |
|
| 1980 |
Calos MP, Miller JH. DNA sequence alteration resulting from a mutation impairing promoter function in the lac repressor gene. Molecular & General Genetics : Mgg. 178: 225-7. PMID 6770231 DOI: 10.1007/Bf00267233 |
0.646 |
|
| 1980 |
Galas DJ, Calos MP, Miller JH. Sequence analysis of Tn9 insertions in the lacZ gene. Journal of Molecular Biology. 144: 19-41. PMID 6260963 DOI: 10.1016/0022-2836(80)90213-2 |
0.649 |
|
| 1980 |
Miller JH, Calos MP, Galas D, Hofer M, Büchel DE, Müller-Hill B. Genetic analysis of transpositions in the lac region of Escherichia coli. Journal of Molecular Biology. 144: 1-18. PMID 6260962 DOI: 10.1016/0022-2836(80)90212-0 |
0.655 |
|
| 1980 |
Calos MP, Miller JH. Transposable elements. Cell. 20: 579-95. PMID 6251969 DOI: 10.1016/0092-8674(80)90305-0 |
0.438 |
|
| 1980 |
Calos MP, Miller JH. Molecular consequences of deletion formation mediated by the transposon Tn9. Nature. 285: 38-41. PMID 6246435 DOI: 10.1038/285038A0 |
0.633 |
|
| 1979 |
Calos M, Johnsrud L, Miller JH. A genetic and sequencing study of IS1 and Tn9 insertions in the Escherichia coli lac operon. Cold Spring Harbor Symposia On Quantitative Biology. 1263-8. PMID 385226 DOI: 10.1101/Sqb.1979.043.01.143 |
0.575 |
|
| 1978 |
Calos MP, Galas D, Miller JH. Genetic studies of the lac repressor. VIII. DNA sequence change resulting from an intragenic duplication. Journal of Molecular Biology. 126: 865-9. PMID 370410 DOI: 10.1016/0022-2836(78)90025-6 |
0.582 |
|
| 1978 |
Johnsrud L, Calos MP, Miller JH. The transposon Tn9 generates a 9 bp repeated sequence during integration. Cell. 15: 1209-19. PMID 365355 DOI: 10.1016/0092-8674(78)90047-8 |
0.629 |
|
| 1978 |
Calos MP. DNA sequence for a low-level promoter of the lac repressor gene and an ‘up’ promoter mutation Nature. 274: 762-765. PMID 355890 DOI: 10.1038/274762A0 |
0.471 |
|
| 1978 |
Calos MP, Johnsrud L, Miller JH. DNA sequence at the integration sites of the insertion element IS1. Cell. 13: 411-8. PMID 350411 DOI: 10.1016/0092-8674(78)90315-X |
0.674 |
|
| Show low-probability matches. |